Medical Advisory Board Member Dr. Sameer Rastogi and the AIIMS Team Publish Study on SDH-deficient GIST titled, "Succinate dehydrogenase deficient GIST: Case series and review of literature from a tertiary care centre in India".
LRG Executive Director Sara Rothschild took part in a CME course produced by Medscape titled 'Improving Outcomes & Quality of Life in Advanced GIST: Discussing the Patient Journey and the Latest Data.'
The LRG Medical Advisory Board issued a statement in response to a NEJM article on telemedicine with the hope that other organizations & physicians will follow suit, advocating for treatment ease & equity.
GIST Mentor John Abrams joins the Board of the LRG.
Deciphera issued a press release today sharing the results of an exploratory analysis of data using circulating tumor DNA (ctDNA) from the INTRIGUE Phase 3 clinical study of ripretinib and announcing plans to initiate INSIGHT.
Our Good News Holiday Campaign is the culmination of our year of "Time to Tell the Stories 2022." In this series, we celebrate the connections, the celebrations, the events and milestones that we’ve been privileged to be a part of this year. Sarah McGoram shares her experience as a patient advocate.
Gift giving is a wonderful opportunity to share a different kind of gift, especially when considering loved ones who may be cancer patients and caregivers.
In this interview with researcher & surgical oncologist Dr. Jason Sicklick shares about his passion for SDH-deficient GIST research.
CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues. The goal of the society is to advance the care of patients with connective tissue tumors.
After three long years, the Annual Night to Fight Cancer benefiting the LRG's research programs, hosted by Jerry Cudzil and Matthew Knopman, took place in-person on October 20th, 2022 at Midtown Loft and Terrace in New York City.
